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An Abnormal Response of Retinoblastoma Cells (Y-79)
to Neurotrophins
Nicole Wagner,1 Kay D. Wagner,2 Mark Sefton,3 Alfredo Rodrı´guez–Te´bar,3 and
Rosemarie Grantyn1
PURPOSE. To clarify the expression of neurotrophins and their receptors in retinoblastoma (Rb)
cells, to elucidate their potential role in the proliferation of neuroectodermal tumor cells, and to
establish conditions for Rb cell differentiation.
METHODS. The Rb-derived cell line Y-79 was grown in serum-free suspension or monolayer culture.
Proliferating and differentiated cells were isolated and submitted to semiquantitative reverse
transcription–polymerase chain reaction (RT-PCR) analysis, immunostaining, and flow cytometry.
The proliferation rate of the cells was estimated by 5-bromo-29-deoxyuridine (BrdU) incorporation,
and the effects of neurotrophins and laminin on BrdU-incorporation, process outgrowth, or
immunostaining were determined.
RESULTS. In contrast to previously studied normal retinal precursor cells, Y-79 cells not only
express nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3), and p75, but also the corresponding high affinity receptors TrkA, TrkB, and TrkC.
Proliferation was stimulated by exogenous and endogenous neurotrophin receptor ligands.
Inhibition of protein kinase phosphorylation with K252a blocked proliferation and promoted
differentiation. The effect of K252a on differentiation was enhanced by the addition of soluble
laminin. After 9 days of combined treatment, the fraction of differentiated cells amounted to
30%, differentiation being characterized by improved attachment, neurite outgrowth, expres-
sion of NF-68, and a loss of glial fibrillary acidic protein (GFAP) and parvalbumin immunore-
activity. These changes were accompanied by a downregulation of TrkB and TrkC, but not TrkA
or p75. Differentiated cells were isolated and further grown in the absence of K252a. However,
despite the high level of TrkA expression in differentiated cells, the addition of NGF had no
effect on their survival.
CONCLUSIONS. A mitogenic action of neurotrophins could contribute to retinal tumor growth. (Invest
Ophthalmol Vis Sci. 2000;41:1932–1939)
In the retina, cell lineage studies have long ago establishedthat postmitotic precursor cells exhibit the potential todifferentiate into any of the various phenotypes that com-
pose the final configuration of this organ.1,2 This fact implies
that environmental factors—namely, the extracellular matrix
proteins and growth factors—can influence the cellular com-
position of the mature retina. Alterations in the responsiveness
of retinal precursor cells to environmental signals may be the
basis for a malignant transformation. It is therefore important
to find out under which conditions signaling pathways identi-
fied during normal retinal development can be reproduced in
ectodermal tumor cells under defined growth conditions.
We have studied the effects of neurotrophins and lami-
nin-1 on retinoblastoma (Rb) cells. Rb is a highly malignant
childhood neoplasm3 that results from the inactivation of a
gene encoding the Rb tumor suppressor protein (pRb).4,5 Mu-
tation of both alleles of the pRb gene inevitably leads to tumor
development. Several cell lines are now available for experi-
mental studies on Rb cells. These include the human Rb cell
line Y-796 that resembles pluripotent embryonic stem cells and
their immature neuronal and glial progeny.7 Although numer-
ous attempts have already been made to induce Y-79 cells to
differentiate, most of the investigated agents, including lami-
nin8,9 and cyclic adenosine monophosphate (cAMP) ana-
logues,10 failed to produce the full set of features expected
from normally developed retinal cells. However, Rb cells were
not yet tested for the effects of neurotrophins.
Neurotrophins constitute a family of growth factors with
diverse functions during central nervous system (CNS) devel-
opment (reviewed in References 11 and 12). The wide range of
responses to nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), and neurotrophin-3 (NT-3) are based on
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their capacity to govern multiple signaling pathways (reviewed
in Reference 13). All neurotrophins activate two distinct types
of plasma membrane receptors: a common low-affinity recep-
tor, p75,14,15 and ligand-specific high-affinity receptors with
tyrosine kinase activity, TrkA,16 TrkB,17,18 and TrkC.19 In the
proliferating retina, neurotrophins have been found to play a
major role in controlling the number and differentiation of
postmitotic migrating precursor cells. In the absence of TrkA,
NGF induces cell death by binding to the p75 receptor.20
Conversely, BDNF and NT-3 promote the survival of retinal
precursor cells that would otherwise die before reaching their
final destinations.21,22 In addition, BDNF and NT-3 contribute
to the differentiation and functional maturation of retinal gan-
glion cells.21,23,24
Neurotrophins are also known as mitogens, but in the CNS
their mitogenic action seems to be confined to nonneuronal
precursor cells.25 The proliferation rate of normal neuron pre-
cursor cells of cortical,26 cerebellar,27 and retinal origin21 was
not affected by neurotrophins. Even in transformed precursor
cells of the CNS the predominant result of neurotrophin treat-
ment was apoptosis.28,29 In some neuroectodermal tumors, a
more favorable outcome was associated with high expression
levels of TrkA or TrkC, because the latter increased apopto-
sis.28,30–32However, Trk receptors were not encountered in
neuronal precursors of the normal retina (see the Discussion
section).
How a given cell population reacts to neurotrophins or
other soluble factors may be influenced by the capacity of
these factors to regulate the cellular response to extracellular
matrix ECM proteins. Experiments with normal neuroepithelial
cells of retinal origin showed that the acquisition of neuronal
properties is stimulated by laminin-1.33 However, the expres-
sion of the laminin-1 receptor subunit a6 requires the presence
of an insulin-like growth factor.34 In neuroblastoma cells, dif-
ferentiation induced by retinoic acid is associated with upregu-
lation of the expression of integrin a1b1.35 In contrast, rapid
proliferation of neuroblastoma cells as a consequence of N-myc
overexpression was reflected in greatly reduced levels of inte-
grin a2 and a3 mRNAs.36 The possible link between respon-
siveness to laminin and neurotrophin receptor activation has
not yet been investigated in retinal tissues.
Thus, the main objective of the present study was to
determine the neurotrophins and neurotrophin receptors ex-
pressed by Rb cells, to elucidate the potential role of neuro-
trophins in the proliferation of neuroectodermal tumor cells,
and to establish in vitro conditions for the differentiation of
retinal tumor cells that could be compared with previously
described results from normal retinal precursors.
A preliminary account of this work has already ap-
peared.37
METHODS
Cell Culture
Stocks of Y-79 human Rb cells (American Type Tissue Culture,
Rockville, MD) were maintained in suspension culture at 37°C
(95% air, 5% CO2) in RPMI 1640 medium, with 2 mM glu-
tamine, 15% fetal calf serum, 100 U/ml penicillin, and 100
mg/ml streptomycin (all obtained from Gibco, Eggenstein, Ger-
many). Before plating, cells were transferred to the same, but
serum-free, medium and kept for at least 1 week in suspension
culture. For attachment cultures, cells were seeded onto 0.1%
poly-D-lysine-coated (Sigma, Deisenhofen, Germany) glass cov-
erslips at a density of 3 3 104 cells/cm2 and maintained in
serum-free medium. The latter was half-changed three times
weekly. Cultures were tested for the effects of NGF (Alomone,
Jerusalem, Israel; 50 ng/ml), K252a (Kamiya, Thousand Oaks,
CA; 100 nM), or laminin from mouse Engelbreth–Holm–Swarm
tumor (20 mg/ ml; Becton Dickinson, Heidelberg, Germany).
Proliferation Assay
After a 30-minute exposure to 5-bromo-29-deoxyuridine (BrdU)
for incorporation into the DNA of replicating cells, proliferat-
ing cells were detected using a BrdU staining kit (Boehringer–
Mannheim, Mannheim, Germany). The label was visualized
with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-in-
dolyl phosphate (BCIP).
Immunostaining
Monolayer cultures were fixed with 1.5% paraformaldehyde
and 1% glutaraldehyde (Sigma). The cells were permeabilized,
and endogenous peroxidases were blocked in a solution of 3%
H2O2 in methanol (1:4) for 5 minutes, washed, and incubated
with the primary antibody for 16 hours at 4°C. The following
primary antibodies were used: monoclonal anti-parvalbumin
mouse IgG1 (clone PA-235; Sigma; 1:500 in phosphate-buffered
saline [PBS] containing 5% normal goat serum), monoclonal
anti-calbindin mouse IgG1 (clone CL-300; Sigma; 1:300 in PBS
containing 5% normal goat serum), and polyclonal anti-calreti-
nin (Chemicon, Temecula, CA; 1:2500 in PBS containing 5%
normal rabbit serum). This was followed by incubation with a
biotinylated secondary antibody (goat anti-mouse; Sigma; 1:200
in PBS 1 1% bovine serum albumin [BSA], for parvalbumin or
calbindin staining, or rabbit anti-goat; Dianova, Hamburg, Ger-
many; 1:200 1 1% bovine serum albumin for calretinin stain-
ing) and application of streptavidin-peroxidase (Sigma). The
latter was visualized with diaminobenzidine and hydrogen per-
oxide (Sigma). For negative controls, primary antibodies were
replaced with normal serum. No significant labeling was seen
under these conditions.
Flow Cytometry
To obtain cultures enriched with differentiated Y-79 cells for
subsequent flow cytometry, monolayer cultures were sub-
jected to an extensive washing procedure. After complete
removal of the cell culture medium, the glass coverslips were
dipped three times into a vessel with PBS. This resulted in a
decrease in the total cell number from 7023 6 183 to 5672 6
356 cells/cm2 and enhanced the fraction of process-bearing
cells from 28.6% 6 1.8% to 60.9% 6 3.4% (n 5 3). Cells were
then treated with ice-cold 0.1 M EDTA-PBS solution and re-
moved from the glass coverslips by a cell scraper. Undifferen-
tiated Y-79 cells were directly taken from suspension cultures.
Both samples were washed with PBS containing 5% BSA and
0.1% NaN3, fixed with 3% paraformaldehyde, and incubated for
3 hours at 4°C with either a glial fibrillary acidic protein (GFAP)
antibody (Sigma; 1:500) or an NF 68 antibody (Sigma; 1:150).
After repeated washes, cells were incubated for 30 minutes in
a fluorescein isothiocyanate–conjugated secondary antibody
(Dianova), washed again, and analyzed in a flow cytometer
(FACS Trak; Becton Dickinson, Heidelberg, Germany).
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Reverse Transcription–Polymerase
Chain Reaction
For reverse transcription–polymerase chain reaction (RT-PCR)
cells were processed as for flow cytometry. Total RNA was
prepared from cells using Trizol reagent (Gibco). RNA was
dissolved in diethyl pyrocarbonate (DEPC)-H2O and first-strand
cDNA synthesis was performed using Superscript II reverse
transcriptase (Gibco) and an oligo-dT primer. PCR reactions
were performed in a thermal cycler (Biometra, Go¨ttingen,
Germany) under the following conditions: denaturation at
94°C for 45 seconds, annealing at 58°C for 45 seconds, and
extension at 72°C for 45 seconds. Twenty-nine cycles of am-
plification were performed. The primers used are given in
Table 1. b-actin amplification was used for semiquantitative
analysis of Trk expression. For negative controls, cDNA was
replaced by bidistilled water. PCR products were analyzed on
0.8% agarose gels stained with ethidium bromide.
Cell Counts and Statistics
Cells in unfixed monolayer cultures were counted under
phase-contrast illumination (3200). The cell density on day in
vitro (DIV) 1 refers to cells in one focal plane only, 3 hours
after plating. Counts were performed visually (cells with pro-
cesses, parvalbumin immunostaining), or automatically, by flu-
orescence-activated cell sorting (GFAP, NF 68). In the former
case, each data point represents the average from 15 fields
(0.418 mm2) in two different dishes and at least three different
experiments.
All data are represented as mean 6 SD. Significance levels
for the differences between the mean values were determined
by an unpaired Student’s t-test and are shown in each graph by
asterisks.
RESULTS
Neurotrophins and Their Receptors in
Proliferating Y-79 Cells
Samples of Y-79 cells were obtained from serum-free suspen-
sion cultures. The expression of mRNA for the neurotrophins
NGF, BDNF, NT-3, and their respective receptors TrkA, TrkB,
and TrkC, as well as the p75 receptor, was analyzed by RT-PCR
(Fig. 1). The messages for all three neurotrophins and each of
the four receptors were detected in proliferating tumor cells, a
situation not encountered in neuronal precursor cells (see the
Discussion section). We therefore decided to examine the
effects that the exposure to neurotrophins may have on Rb
cells grown in serum-free monolayer cultures.
Proliferative Effects of Neurotrophins
Neurotrophins were added at concentrations of 50 ng/ml
(NGF) or 10 ng/ml (BDNF or NT-3). After 9 days in vitro, a clear
difference was observed between control and test cultures
(Figs. 2B, 2D). Neurotrophin-treated cultures were denser and
exclusively composed of round or pleomorphic cells, some of
them forming colonies. Cell counts revealed that neurotro-
phins stimulated proliferation at any time after plating. After 9
days in the presence of NGF, the average cell density nearly
doubled (Fig. 2G). Similar effects were found with both BDNF
and NT-3 (n 5 6, results not shown).
It is very likely that the proliferative response to exoge-
nous neurotrophins was mediated by Trk receptors, because
simultaneous treatment with the tyrosine kinase inhibitor
K252a (100 nM) prevented the neurotrophin-induced increase
in cell density (compare Figs. 2D and 2F). At DIV9 the density
TABLE 1. Sequences of Oligonucleotide Primers and Predicted Sizes
of RT-PCR Products
Gene Orientation 5*–3* Sequence
Predicted
Sizes of
Amplified
Fragments
NGF Sense TTCTGATCGGCATACAGGCG 552 bp
Antisense TGCTTTGAGTCAATGCCCCG
BDNF Sense TTGGTTGCATGAAGGCTGCC 391 bp
Antisense ACTGTCACACACGCTCAGCT
NT3 Sense TCGCTTATCTCCGTGGCATC 726 bp
Antisense CTCGACAAGGCACACACACA
TrkA Sense ATTTTGTGCACCGGGACCTG 190 bp
Antisense CGCTCTCGGTGGTGAACTTA
TrkB Sense TGGATAAGGTGGCATGGACC 437 bp
Antisense TGGATTGCCCACCAGGATCA
TrkC Sense CAACTGCAGCTGTGACATCC 384 bp
Antisense AGTGTTGATGGACTGCAGCC
p75 Sense CAGACAGCTCAGATGTGCTGC 747 bp
Antisense TCTCTGCAGGCACAAGGGCTT
b-actin Sense TTCTACAATGAGCTGCGTGTG 591 bp
Antisense CGTCACACTTCATGATGGAGT
FIGURE 1. RT-PCR analysis indicates that Y-79 cells express neurotro-
phins and neurotrophin receptors. Top: Ethidium bromide-stained aga-
rose gels of the PCR products amplified with primers specific for NGF,
NT3, and BDNF. Bottom: Ethidium bromide-stained gels of the PCR
products amplified with primers specific for p75, TrkA, TrkB, and TrkC
and, in all cases, b-actin (591-bp PCR product). Molecular weight
markers are shown in the lanes on the left, and the numbers indicate
the predicted size of the specific PCR products (in bp). Left lanes:
negative controls, with bidistilled water instead of cDNA in the PCR
reaction (n 5 3 in all cases).
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of K252a- and NGF-treated cultures decreased to 77% of the
control value at DIV1 (Fig. 2G, compare filled circles with open
squares and triangles). This density was similar to that of
cultures treated with K252a alone, suggesting that proliferation
could in part be maintained by endogenous Trk receptor li-
gands.
To estimate the rate of proliferation in Y-79 cultures more
directly, we determined the fraction of BrdU-incorporating
cells under various conditions. Cells were labeled at DIV9 by a
single 30-minute exposure to BrdU, and cultures treated with
NGF, K252a, and NGF 1 K252a were compared with un-
treated control cultures (Fig. 2H). Treatment with NGF in-
duced a 2.7-fold increase in the fraction of BrdU-labeled cells,
whereas K252a decreased the fraction of BrdU-labeled cells to
36.6% (in the absence of NGF) and to 32.8% (in the presence
of NGF). Because the K252a concentration was sufficient to
block all Trk receptors,38,39 we conclude that, in the absence
of added NGF, proliferation was largely dependent on Trk
receptor activation by ligands derived from the tumor cells
through an autocrine or paracrine route.
Differentiating Effects of Neurotrophin
Receptor Blockade
A characteristic feature of the cultures in which neurotrophin-
induced proliferation had been blocked for 9 days with K252a
was the presence of cells that had processes longer than one
cell diameter (see Fig. 2F). This indicated that some degree of
differentiation had occurred in these cultures. To provide mo-
lecular evidence that the process-bearing cells were in fact
differentiated, Y-79 cultures were characterized by immunocy-
tochemistry. Cells possessing these long processes downregu-
lated the expression of the calcium-binding protein parvalbu-
min (Figs. 3A, 3B, arrowheads), whereas round cells without
processes were strongly stained. Process outgrowth and loss of
parvalbumin immunostaining were regarded as evidence of
Y-79 cell differentiation. Flow cytometry confirmed that both
criteria actually reflect the acquisition of a neuronlike pheno-
type (described later).
It should be mentioned that immunocytochemical inves-
tigation of two other calcium-binding proteins, calbindin and
calretinin, did not reveal significant differences between round
cells without processes and process-bearing cells. In untreated
control cultures, 96% 6 1% and 94% 6 3% of the cells were
immunoreactive for calbindin and calretinin, respectively. In
treated monolayer cultures, the fraction of calbindin- and cal-
retinin-immunoreactive cells amounted to 92% 6 3% and 91%
6 1%, respectively.
The criteria process outgrowth and parvalbumin immuno-
staining were used to estimate the increase in the number of
differentiated cells in the presence of K252a, laminin, or both
(Figs. 3C, 3D). K252a increased the density of process-bearing
or parvalbumin-negative cells 6.8-fold and 5.5-fold, respec-
tively.
Treatment with laminin has been reported to produce a
degree of morphologic differentiation in Y-79 cultures.8 Under
our culture conditions, the addition of laminin in soluble form
increased the density of differentiated Y-79 cells 4.4-fold (pro-
cess outgrowth) or 4.3-fold (parvalbumin immunostaining),
whereas the proliferation rate remained unchanged (three ex-
periments with BrdU incorporation, as in Fig. 2H). The effects
of both K252a and of laminin were further augmented when
both treatments were combined. Therefore, to obtain a maxi-
mal differentiation response, Y-79 cultures were treated for 9
days with both K252a (100 nM) and laminin-1 (20 mg/ml). With
this standard protocol, nearly one third (30%) of the Y-79 cells
were considered to be differentiated. This figure should be
compared with only 3% of differentiated cells in the untreated
controls in serum-free monolayer culture.
Neuronlike Phenotype of Differentiated
Y-79 Cells
In other pediatric brain tumors, increased GFAP expression has
been associated with less mature cell types and correlated with
FIGURE 2. NGF stimulates proliferation of Y-79 cells by Trk receptor
activation. Photomicrographs of cultured Y-79 cells after 3 hours (A, C,
and E) and 9 days in monolayer culture (B, D, and F). (A, B) Cells in
defined medium without additions. (C, D) Cells treated with 50 ng/ml
NGF. (E, F) Cells treated with 50 ng/ml NGF and 100 nM K252a (n 5
6). Note the strong increase in the cell number in cultures treated with
NGF (E) and the presence of processes in cells treated with the Trk
receptor inhibitor (F). (G) Plot of cell density versus time in monolayer
culture under different culture conditions (n 5 6). (H) Number of
cells/cm2 incorporating BrdU at DIV 9 (n 5 3). Asterisks show results
of Student’s t-test. In this and Figures 3 through 6: *P , 0.05, **P ,
0.01, and ***P , 0.001.
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a poorer prognosis.40 It could therefore be expected that, in
cultures treated with K252a and laminin, differentiated Y-79
cells loose GFAP expression. We tested this possibility by flow
cytometry. Differentiated cells were obtained by submitting
treated Y-79 monolayer cultures to three strong washes with
PBS. This removed the nonadherent cells and created a bias for
differentiated neuronlike cells. Proliferating cells were ob-
tained from serum-free suspension cultures. Differentiated and
proliferating Y-79 cells were incubated with antibodies against
GFAP and NF 68 as markers for glial and neuronal cells, respec-
tively. Flow cytometric analysis (Fig. 4) revealed that differen-
tiated cells were indeed devoid of GFAP but expressed the
neuronal marker NF 68. In contrast, proliferating Y-79 cells
showed both markers. We thus concluded that differentiated
Y-79 cells acquire a neuronlike phenotype.
Persistence of TrkA Receptors in Differentiated
Neuronlike Y-79 Cells
To find out whether differentiation changed the expression of
neurotrophin receptors, semiquantitative RT-PCR analysis was
performed in differentiated and proliferating Y-79 cells, pre-
pared as for flow cytometry. The expression of both TrkA and
p75 clearly persisted in the differentiated cell population,
whereas TrkB and TrkC expression decreased to below detec-
tion level (Fig 5).
To address what might be the function of TrkA and p75 in
differentiated Y-79 cells we considered the possibility that
these receptors control, as in neurons, survival. To clarify this
point, differentiated cells were again isolated by washing off
the nonadhering cells. This procedure also removed the rem-
nants of K252a, facilitating the response of newly expressed
neurotrophin receptors to exogenous NGF (50 and 100 ng/ml).
However, an effect of NGF on the survival of Y-79 cells was not
observed (Fig. 6). Both in the presence and absence of NGF,
cell density decreased within 4 days to approximately 50%.
Thus, the likely fate of differentiated neuronlike Y-79 cells was
to die, and NGF could neither prevent nor facilitate this pro-
cess.
DISCUSSION
The results of the present study led us to conclude that neu-
rotrophins can contribute to the progression of Rb. Y-79 cells
express mRNA for NGF, BDNF, NT-3, and the corresponding
receptors TrkA, TrkB, and TrkC, and p75. Even under condi-
tions of serum-free monolayer culture, the number of Y-79 cells
significantly increased in the presence of added neurotrophins,
and decreased when protein kinases were inhibited. Thus,
proliferation of Rb cells was stimulated by exogenous as well as
endogenous neurotrophins. Correspondingly, differentiation
could be initiated by neurotrophin receptor block.
The present tumor cell differentiation model is based on
the use of K252a38,41 which has already been applied in other
tumor models.42,43 The essential point here is that K252 not
only acts as an antiproliferative but also as a differentiating
agent. It is, however, possible that the double antiproliferative,
as well as differentiating effect of K252a reflects the inhibition
of several tyrosine kinases. Rubin et al.44 identified and char-
acterized a mitogenic factor released by Y-79 cells, the so-
called Rb-derived growth factor (RDGF). Y-79 cells were found
to exhibit significant protein tyrosine kinase activity, and ty-
rosine phosphorylation was stimulated in the presence of
RDGF.45
To what extent the antiproliferative effect of K252a is a
prerequisite for the subsequent differentiation of Y-79 cells
cannot be answered with certainty. The experiments with
laminin were undertaken to satisfy the potential need for ad-
ditional signals. Laminin-1 stimulates neuron differentiation in-
ducing neurite outgrowth (reviewed in Reference 46). In the
present experiments, added laminin indeed increased the frac-
tion of differentiated neurons beyond the level achieved with
K252a alone. But in contrast to normal retinal precursor cells in
vitro,33 the presence of laminin-1 was not sufficient to drive all
the cells into differentiation. Moreover, differentiated Y-79
cells had similar neuronlike properties when growing on an-
other adhesive substrate. This could, however, be related to
the low levels of expression of the corresponding integrin
FIGURE 3. Laminin and K252a increase the number of differentiated and
parvalbumin-negative Y-79 cells. (A, B) Photomicrographs of differenti-
ated Y-79 cells under phase-contrast (A) and bright-field illumination (B).
(C) Number of cells with processes per square centimeter at DIV 9 after
different treatment (n 5 6). (D) Number of parvalbumin-immunonegative
cells per square centimeter (n 5 5). Same conditions as in (C). Student’s
t-tests were performed to reveal significant differences between treated
and untreated cultures (asterisks) and laminin-treated cultures in the
presence and absence of K252a (horizontal bar).
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receptor subunit a634 or other changes in integrin receptor
expression, which in turn would require other ECM compo-
nents to induce neurite outgrowth. Indeed, a recent study
identified an epitope on the internal domain of integrin a3 in
medulloblastoma cells that has not been observed in normal
brain tissue.47
Although normal retinal precursors1,2 as well as Y-79
cells7 have been regarded as pluripotential, nearly all postmi-
totic Y-79 cells acquired a neuronlike phenotype. Further at-
tempts to clarify the identity of the neuronlike Y-79 cells
revealed some similarities with horizontal cells. Differentiated
cells stained for g-aminobutyric acid (GABA), had no axons and
failed to generate action potentials. They also showed no
immunoreactivity to Thy-1, a marker of ganglion cells; 3BA8, a
marker of amacrine cells; and 4F3, a marker of Mu¨ller cells
(Offermann and Grantyn, unpublished data, 1999). However,
the absence of parvalbumin is not consistent with the assump-
tion that differentiated Y-79 cells are horizontal cells.48,49 We
therefore conclude that postmitotic Y-79 cells did not com-
pletely reproduce any of the known retinal cell types.
How a given tissue responds to environmental factors
depends on the available receptor forms and the signaling
pathways recruited on receptor activation. With regard to
NGF, it is already known that the final outcome of NGF treat-
ment depends on the relative levels of p75 and TrkA expres-
sion. For instance, oligodendrocytes could be rescued from
p75-mediated cell death by inducing the expression of TrkA.50
In the developing retina, NGF promotes apoptosis only in cells
that express p75 and not TrkA.20 This expression pattern is
characteristic of neuron precursor cells at the earliest stages of
retinal development. It is very likely that these cells also have
no TrkB and TrkC (Rodrı´guez–Te´bar, unpublished data, 1989).
Undifferentiated Y-79 cells, in contrast, clearly expressed all
three Trk receptors, and an apoptotic effect of NGF, if present,
was at least not obvious. Thus, the difference in the responses
of normal retinal precursor cells and neuroectodermal tumor
cells may be explained by qualitative and/or quantitative dif-
ferences in the expression of p75 and Trk receptors. Whereas
normal precursor cells preferentially express p75, tumor cells
express Trk receptors and perhaps smaller amounts of p75. A
quantitative analysis of p75 and Trk expression in human Rb
FIGURE 4. Flow cytometric analysis of GFAP and NF 68 immunofluorescence in treated and untreated Y-79 cells. (A through E) Size and
fluorescence of immunostained Y-79 cells. (A, C, and D) Y-79 cells from serum-free suspension cultures. (B, E) Y-79 cells at DIV 9 after standard
treatment with K252a and laminin. (C) Cells after staining without primary antibody, serving as control for (A, B, D, E). (A, B, and F) After GFAP
immunostaining. (D, E, and G) After NF 68 immunostaining. (F, G) Overlay histograms of GFAP and NF 68 immunofluorescence. Note the decrease
of GFAP and increase of NF 68 immunofluorescence in differentiated Y-79 cells.
FIGURE 5. Downregulation of TrkB and TrkC, but not TrkA, in differ-
entiated Y-79 cells revealed by semiquantitative RT-PCR. Ethidium
bromide–stained agarose gels of the PCR products amplified with
primers specific for p75, TrkA, TrkB, and TrkC. In all cases, b-actin
expression was used as an internal standard. Molecular weight markers
are shown in the lanes on the far left; numbers indicate the predicted
size of the specific PCR products (in base pairs). Untreated cultures
were maintained for 9 days in serum-free RPMI 1640 with N-2 supple-
ment. Treated cultures received in addition K252a (100 nM) and
laminin (20 mg/ml). Left lanes: negative controls, with bidistilled water
instead of cDNA in the PCR reaction (n 5 3 in all cases).
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cells and retinal precursor cells is needed to validate this
hypothesis. This in turn may lead to a better understanding of
the role of p75 in the development of CNS tumors whereby an
imbalance between p75 and Trk expression may underlie the
transition from a normally proliferating to a transformed state
of the tissue. It has already been shown in epithelial tumors of
the prostate that a downregulation of p75 marks the beginning
of a malignant state of the cells.51 Moreover, in mouse sensory
ganglion cells, Rb gene inactivation resulted in a decreased
expression of p7552 and the WT1 tumor-suppressor protein
downregulated p75 promotor activity in kidney cells.53 Taken
together, these observations point to the possibility that p75
could act as a target of tumor-suppressor factors, first of all
pRb. Inactivation of the latter in Y-79 cells could result in low
expression levels of p75.
In contrast to the developmental increase in the overall
expression of Trk receptors in the normal retina,22,54,55 post-
mitotic Y-79 cells lost the message for TrkB and TrkC. The
mechanism of this process is not yet clear, but it may be a sign
of reversed malignancy. In any case, it was associated with a
downregulation of parvalbumin immunoreactivity, thereby
supporting previous observations that Trk receptor activation
controls the expression of calcium-binding proteins. Interest-
ingly, a suppression of TrkB expression in the developing rat
retina by antisense oligonucleotides was also accompanied by
a decrease in parvalbumin staining.56
In conclusion, the present experimental model seems to
be well suited to study the mechanisms underlying the control
of proliferation as well as various aspects of neuron differenti-
ation. The proliferative response to neurotrophins in malignant
cells without pRb was tentatively explained by their unusually
high expression of Trk receptors when compared with normal
neuroectodermal cells. Finally, it seems very likely that endog-
enous neurotrophins contribute to the malignant growth
of Rb.
Acknowledgments
The authors thank Holger Scholz for helpful comments on an earlier
version of the manuscript, and Karin Prziezdziecki and Andrea Schu¨tz
for expert technical assistance.
References
1. Turner DL, Cepko CL. A common progenitor for neurons and glia
persists in rat retina late in development. Nature. 1987;328:131–
136.
2. Wetts R, Serbedzija GN, Fraser SE. Cell lineage analysis reveals
multipotent precursors in the ciliary margin of the frog retina. Dev
Biol. 1989;136:254–263.
3. Brodeur GM. Genetics of embryonal tumours of childhood: retino-
blastoma, Wilms’ tumour and neuroblastoma. Cancer Surveys.
1995;25:67–99.
4. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with
properties of the gene that predisposes to retinoblastoma and
osteosarcoma. Nature. 1986;323:643–646.
5. Sparkes RS, Murphree AL, Lingua RW, et al. Gene for hereditary
retinoblastoma assigned to human chromosome 13 by linkage to
esterase D. Science. 1983;219:971–973.
6. Reid TW, Albert DM, Rabson AS, et al. Characteristics of an estab-
lished cell line of retinoblastoma. J Natl Cancer Inst. 1974;53:347–
352.
7. Kyritsis AP, Tsokos M, Triche TJ, Chader GJ. Retinoblastoma: a
primitive tumor with multipotential characteristics. Invest Oph-
thalmol Vis Sci. 1986;27:1760–1764.
8. Albini A, Noonan DM, Melchiori A, et al. Laminin-induced retino-
blastoma cell differentiation: possible involvement of a 100-kDa
cell-surface laminin-binding protein. Proc Natl Acad Sci USA.
1992;89:2257–2261.
9. Campbell MA, Chader GJ. Effects of laminin on attachment,
growth and differentiation of cultured Y-79 retinoblastoma cells.
Invest Ophthalmol Vis Sci. 1988;29:1517–1522.
10. Fassina G, Aluigi MG, Gentleman S, et al. The cAMP analog 8-Cl-
cAMP inhibits growth and induces differentiation and apoptosis in
retinoblastoma cells. Int J Cancer. 1997;72:1088–1094.
11. Chao MV. Neurotrophin receptors: a window into neuronal differ-
entiation. Neuron. 1992;9:583–593.
12. Davies AM. The role of neurotrophins in the developing nervous
system. J Neurobiol. 1994;25:1334–1348.
13. Kaplan DR, Miller FD. Signal transduction by the neurotrophin
receptors. Curr Opin Cell Biol. 1997;9:213–221.
14. Rodrı´guez–Te´bar A, Dechant G, Barde Y-A. Binding of brain-de-
rived neurotrophic factor to the nerve growth factor receptor.
Neuron. 1990;4:487–492.
FIGURE 6. Isolation of differentiated cells and test for survival-promot-
ing effect of NGF on these cells. (A) Photomicrograph of a culture at
DIV9 after standard treatment with K252a and laminin. (B) Same
culture after three strong washes in PBS (time 0). This procedure
produces a bias for differentiated cells. (C) Counts of cells with neu-
rites longer than soma diameter at time 0 and after 4 days of treatment
with NGF at the indicated concentrations. Increased survival was not
observed (n 5 3).
1938 Wagner et al. IOVS, June 2000, Vol. 41, No. 7
15. Rodrı´guez–Te´bar A, Dechant G, Go¨tz R, Barde Y-A. Binding of
neurotrophin-3 to its neuronal receptors and interactions with
nerve growth factor and brain-derived neurotrophic factor. EMBO
J. 1992;11:917–922.
16. Kaplan DR, Martı´n–Zanca D, Parada LF. Tyrosine phosphorylation
and tyrosine kinase activity of the trk proto-oncogene product
induced by NGF. Nature. 1991;350:158–160.
17. Klein R, Nanduri V, Jing S, et al. The trkB tyrosine protein kinase
is a receptor for brain-derived neurotrophic factor and neurotro-
phin-3. Cell. 1991;66:395–403.
18. Soppet D, Escandon E, Maragos J, et al. The neurotrophic factors
brain-derived neurotrophic factor and neurotrophin-3 are ligands
for the trkB tyrosine kinase receptor. Cell. 1991;65:895–903.
19. Lamballe F, Tapley P, Barbacid M. trkC encodes multiple neuro-
trophin-3 receptors with distinct biological properties and sub-
strate specificities. EMBO J. 1993;12:3083–3094.
20. Frade JM, Rodrı´guez–Te´bar A, Barde Y-A. Induction of cell death
by endogenous nerve growth factor through its p75 receptor.
Nature. 1996;383:166–168.
21. Bovolenta P, Frade JM, Martı´ E, et al. Neurotrophin-3 antibodies
disrupt the normal development of the chick retina. J Neurosci.
1996;16:4402–4410.
22. Frade JM, Bovolenta P, Martı´nez–Morales JR, Arribas A, Rodrı´guez–
Te´bar A. Control of early cell death by BDNF in the chick retina.
Development. 1997;124:3313–3320.
23. Cellerino A, Carroll P, Thoenen H, Barde Y-A. Reduced size of
retinal ganglion cell axons and CNS-specific hypomyelination in
mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci.
1997;9:397–408.
24. Rothe T, Ba¨hring R, Carroll P, Grantyn R. Repetitive firing deficits
and reduced sodium current density in retinal ganglion cells de-
veloping in the absence of BDNF. J Neurobiol. 1999.
25. McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and
brain-derived neurotrophic factor induce oligodendrocyte prolif-
eration and myelination of regenerating axons in the contused
adult rat spinal cord. J Neurosci. 1998;18:5354–5365.
26. Ghosh A, Greenberg ME. Distinct roles for bFGF and NT-3 in the
regulation of cortical neurogenesis. Neuron. 1995;15:89–103.
27. Gao WQ, Zheng JL, Karihaloo M. Neurotrophin-4/5 (NT-4/5) and
brain-derived neurotrophic factor (BDNF) act at later stages of
cerebellar granule cell differentiation. J Neurosci. 1995;15:2656–
2667.
28. Kim JY, Sutton ME, Lu DJ, et al. Activation of neurotrophin-3
receptor TrkC induces apoptosis in medulloblastomas. Cancer
Res. 1999;59:711–719.
29. Muragaki Y, Chou TT, Kaplan DR, Trojanowski JQ, Lee VM-Y.
Nerve growth factor induces apoptosis in human medulloblastoma
cell lines that express trkA receptors. J Neurosci. 1997;17:530–
542.
30. Ryden M, Sehgal R, Dominici C, Schilling FH, Ibanez CF, Kogner P.
Expression of mRNA for the neurotrophin receptor trkC in neu-
roblastomas with favourable tumour stage and good prognosis.
Br J Cancer. 1996;74:773–779.
31. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL.
Expression of the neurotrophin receptor TrkC is linked to a favor-
able outcome in medulloblastoma. Proc Natl Acad Sci USA. 1994;
91:12867–12871.
32. Yamashiro DJ, Liu XG, Lee CP, et al. Expression and function of
Trk-C in favourable human neuroblastomas. Eur J Cancer. 1997;
33:2054–2057.
33. Frade JM, Martı´nez–Morales JR, Rodrı´guez–Te´bar A. Laminin-1 se-
lectively stimulates neuron generation from cultured retinal neu-
roepithelial cells. Exp Cell Res. 1996;222:140–149.
34. Frade JM, Martı´ E, Bovolenta P, et al. Insulin-like growth factor-1
stimulates neurogenesis in chick retina by regulating expression of
the a6 integrin subunit. Development. 1996;122:2497–2506.
35. Rossino P, Defilippi P, Silengo L, Tarone G. Up-regulation of the
integrin alpha 1/beta 1 in human neuroblastoma cells differenti-
ated by retinoic acid: correlation with increased neurite outgrowth
response to laminin. Cell Regul. 1991;2:1021–1033.
36. Judware R, Culp LA. Concomitant down-regulation of expression
of integrin subunits by N-myc in human neuroblastoma cells:
differential regulation of alpha2, alpha3 and beta1. Oncogene.
1997;14:1341–1350.
37. Offermann N, Grantyn R. Effects of laminin and neurotrophins on
proliferation and differentiation of retinoblastoma cells in vitro
(abstract). Eur J Neurosci. 1998;10:371.
38. Knu¨sel B, Hefti F. K-252b is a selective and nontoxic inhibitor of
nerve growth factor action on cultured brain neurons. J Neuro-
chem. 1991;57:955–962.
39. Oberstar JV, Challacombe JF, Roche FK, Letourneau PC. Concen-
tration-dependent stimulation and inhibition of growth cone be-
havior and neurite elongation by protein kinase inhibitors KT5926
and K-252a. J Neurobiol. 1997;33:161–171.
40. Janss AJ, Yachnis AT, Silber JH, et al. Glial differentiation predicts
poor clinical outcome in primitive neuroectodermal brain tumors.
Ann Neurol. 1996;39:481–489.
41. Nye SH, Squinto SP, Glass DJ, et al. K-252a and staurosporine
selectively block autophosphorylation of neurotrophin receptors
and neurotrophin-mediated responses. Mol Biol Cell. 1992;3:677–
686.
42. Chin LS, Murray SF, Zitnay KM, Rami B. K252a inhibits prolifera-
tion of glioma cells by blocking platelet-derived growth factor
signal transduction. Clin Cancer Res. 1997;3:771–776.
43. Delsite R, Djakiew D. Anti-proliferative effect of the kinase inhib-
itor K252a on human prostatic carcinoma cell lines. J Androl.
1996;17:481–490.
44. Rubin NA, Tarsio JF, Borthwick AC, Gregerson DS, Reid TW.
Identification and characterization of a growth factor secreted by
an established cell line of human retinoblastoma maintained in
serum-free medium. Vision Res. 1981;21:105–112.
45. Kyritsis AP, Tsokos M, Chader GJ. Control of retinoblastoma cell
growth by differentiating agents: current work and future direc-
tions. Anticancer Res. 1986;6:465–474.
46. Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and
their receptors: functions in neural development. Annu Rev Neu-
rosci. 1991;14:531–570.
47. Kishima H, Shimizu K, Tamura K, et al. Monoclonal antibody
ONS-M21 recognizes integrin alpha3 in gliomas and medulloblas-
tomas. Br J Cancer. 1999;79:333–339.
48. Celio MR. Calbindin D-28k and parvalbumin in the rat nervous
system. Neuroscience. 1990;35:375–475.
49. Endo T, Kobayashi M, Kobayashi S, Onaya T. Immunocytochemi-
cal and biochemical localization of parvalbumin in the retina. Cell
Tissue Res. 1986;243:213–217.
50. Yoon SO, Casaccia–Bonnefil P, Carter B, Chao MV. Competitive
signaling between TrkA and p75 nerve growth factor receptors
determines cell survival. J Neurosci. 1998;18:3273–3281.
51. Perez M, Regan T, Pflug B, Lynch J, Djakiew D. Loss of low-affinity
nerve growth factor receptor during malignant transformation of
the human prostate. Prostate. 1997;30:274–279.
52. Lee EY, Hu N, Yuan SS, et al. Dual roles of the retinoblastoma
protein in cell cycle regulation and neuron differentiation. Genes
Dev. 1994;8:2008–2021.
53. Poukka H, Kallio PJ, Janne OA, Palvimo JJ. Regulation of the
rat p75 neurotrophin receptor promoter by GC element
binding proteins. Biochem Biophys Res Commun. 1996;229:
565–570.
54. Hallbo¨o¨k F, Ba¨ckstro¨m A, Kullander K, Ebendal T, Carri NG.
Expression of neurotrophins and Trk receptors in the avian retina.
J Comp Neurol. 1996;364:664–676.
55. Hallbo¨o¨k F, Iba´n˜ez CF, Persson H. Cellular localization of brain-
derived neurotrophic factor and neurotrophin-3 mRNA in the early
chicken embryo. Eur J Neurosci. 1993;5:1–14.
56. Rickman DW, Rickman CB. Suppression of trkB expression by
antisense oligonucleotides alters a neuronal phenotype in the rod
pathway of the developing rat retina. Proc Natl Acad Sci USA.
1996;93:12564–12569.
IOVS, June 2000, Vol. 41, No. 7 Neurotrophins and Their Receptors in Y-79 Cells 1939
